Ebiox Completes Water Sterilisation Distribution Agreement

Ebiox are extremely excited to announce the completion of a global distribution agreement (excluding North and South America) for the Water Sterilisation technology developed by Citrox. The agreement covers both healthcare and leisure markets.

The Water Sterilisation product is based on a solution which contains a patented antibacterial, antiviral, antifungal and sporicidal complex of natural bioflavanoids mixed with fruit acids.

Shown to be highly effective in killing the micro-organisms that could contaminate water, the Ebiox Water Sterilisation Solution is perfect for sterilising in a variety of different applications including, drinking water, water storage containers and water systems.
The Ebiox Water Sterilisation Solution is plant derived and is non-toxic, non-corrosive, organic, biodegradable as well as environmentally friendly as oppossed to other solutions which are based on chlorine and hypochlorite.

It is completely non-harmful. After sterilisation, water remains untainted and can be  used for drinking, boiling and showering as normal.

The profile of illnesses sourced from contaminated water is beginning to rise, especially in relation to psuedomonas outbreaks. It is the strategy of Ebiox to be able to offer key markets a solution package for Infection Prevention and Control, the Water Sterilisation product compliments this strategy extremely well.

New Tests for Trionic Products

User Demands Are Met With New Testing
Ebiox has commissioned more extensive tests as users demand stringent testing of products claiming to have an impact on Healthcare Acquired Infections.
We can report strong passes of the test protocols set by the European Standards, EN13624, EN13727 and EN14348. These cover the Trionic products A2Z, Spray and Wipes.
Jeff Smith, Ebiox’s Commercial Director, said “It is key we keep our product testing up to date ensuring that we meet the highest standards giving confidence of the products efficacy to our current and new users”.
The new test reports can be downloaded as pdf files from http://www.ebiox.co.uk

The Use of Alcohol Based Hand Rubs and the Outbreaks of Norovirus.

Every year the outbreaks in our hospitals just here in the UK of Norovirus (Winter Vomiting Bug) has a major impact on patients health outcomes, smooth operation of wards impacted by closures, the cost of related to these patient health, ward closures, deep cleaning, staff sickness and so on.

It is a well known fact that Alcohol Based Hand Rubs have very little if at all any impact on the control of Norovirus and the key vehicle for spreading the virus is our hands.

Infection: prevention and control of healthcare-associated infections in primary and community care.

Commissioned by the National Institute for Health and Clinical Excellence

Highlights of recommendations proposed for primary and community care:

Decontaminate hands preferably with a hand rub (conforming to current British Standards),

except in the following circumstances, when liquid soap and water must be used: 

When hands are visibly soiled or potentially contaminated with body fluids or in clinical situations where there is potential for the spread of alcohol-resistant organisms (such as norovirus, Clostridium difficile, or organisms that cause diarrhoeal illness).

For many years the use of ABHR's has been pushed as a method of hand hygiene and now is seen as a replacement for hand washing by healthcare workers, patients and visitors. With the visibility of so many dispensers there is a false "security" of the use of ABHR's surrounding Norovirus. People believe they are doing the right thing.

With the outbreak of Norovirus in the hospital and care environment staff, patients and visitors are rightly so encouraged to be diligent about hand hygiene, but how many of those using the ABHR dispensers know that really and truly they are having no impact on the spread of Norovirus by hand transmission.

The use of ABHR's has become a routine practice particularly surrounding the five moments of hand hygiene issued by the WHO. This without doubt has had a major impact on Healthcare Acquired Infections, but it is not the "be all and end all". For the same reasons ABHR's came to the fore hand washing with soap and water itself throws up a number of issues.

So it is time to continue to educate everyone about hand hygiene it's importance and viable products to use to enable high compliance of use and a true broad spectrum efficacy.

There should be questions being asked about current practice and products used as the outbreaks of Norovirus continue to interrupt healthcare systems in many countries.

Why are the CDC continuing to recommend solely the use of ABHR's when the following statement has been made by a key member:

A survey of 161 long-term care facilities in the United States presented at an American College of Preventative Medicine meeting in February revealed an association between the preferential use of alcohol-based hand sanitizers for routine hand hygiene with an increased risk for outbreaks of norovirus, the highly infectious virus that causes most cases of acute gastroenteritis

Of the 45 facilities that reported preferential use of alcohol-based hand sanitizers in a recent survey, 53% experienced a confirmed outbreak of norovirus, compared with 18% of the 17 facilities that used hand sanitizers less often than soap and water.

"...these findings indicate that alcohol-based hand sanitizers might be “suboptimal in controlling the spread of noroviruses,” said Dr. David Blaney of the Epidemic Intelligence Service at the US Centers for Disease Control and Prevention (CDC).

What is an alternative, Natural Esense from Ebiox Ltd UK.

www.ebiox.co.uk

sales@ebiox.co.uk

Ebiox Looking to Expand into The Far East. Distributors Required.

Ebiox is looking to expand it's distributor base into The Far East so we are looking for appropriate partners to grow our succesful product portfolio.

We are a company based in the UK developing, manufacturing and marketing a range of infection control products.

We have an evolving distributor network which we are growing with a controlled and strategic approach.

Our portfolio continues to expand with what we believe are innovative products. We are about to launch a new Hand Hygiene and Surgical Disinfection rub which is developed using only naturally based actives and ingredients.

We are looking for distributors in your region and would be keen to see if there is any potential for developing a distributor partnership with you.

Please visit our website www.ebiox.co.uk to gain more information

I look forward to hearing from you in the future.
Best Regards

Paul

Paul Blenkinsopp

Sales and Marketing Director

Ebiox Limited

paul.blenkinsopp@ebiox.co.uk

+44 7775 731198

Ebiox Looking to Expand into Eastern Europe. Distributors Required.

Ebiox is looking to expand it's distributor base into Eastern Europe and we are looking for appropriate partners to grow our succesful product portfolio.

We are a company based in the UK developing, manufacturing and marketing a range of infection control products. 

We have an evolving distributor network which we are growing with a controlled and strategic approach. 

Our portfolio continues to expand with what we believe are innovative products. We are about to launch a new Hand Hygiene and Surgical Disinfection rub which is developed using only naturally based actives and ingredients. 

We are looking for distributors in your region and would be keen to see if there is any potential for developing a distributor partnership with you. 

Please visit our website www.ebiox.co.uk to gain more information 

I look forward to hearing from you in the future. 
Best Regards

Paul

Paul Blenkinsopp

Sales and Marketing Director

Ebiox Limited

paul.blenkinsopp@ebiox.co.uk

+44 7775 731198

The Questions Over the Use of ABHR's Continue to Grow

Since the uptake of Alcohol Based Hand Rubs for one of the key aspects of infection prevention and control, hand hygiene, recommendations for it's use has come from such influential bodies such as the WHO and CDC.

The CDC last reviewed its recommendations as far back as 2002. Since that date the use of ABHR's has unquestionably had an impact on infection control and infection rates, however with the experience of use over this time questions are beginning to be raised over the use of ABHR's.

The following study is one of many that surely should stimulate a review of both the recommendations made by both bodies, especially as there are a number of excellent alternatives now available which in 2002 was not the case.

Edwards, Patel and Wareham had a study published in The Journal of Medical Microbiology as long ago as 2007. "Low concentrations of commercial alcohol hand rubs facilitate growth of secretions of extracellular proteins by multidrug-resitant strains of Acinetobacter baumannii"

Just one small section of this in-depth study raises significant questions, "As ABHR's are extensively used in health care settings, the authors set out to determine whether the hand rubs could also influence the growth of prevalent multidrug-resistant strains circulating in UK hospitals. A significant increase in growth was observed"!!!

During the study commercially available ABHR's were used, Skinman, Softalind, Spirigel and Purell.

It makes fascinating reading, but more importantly it strengthens the argument along with many other factors, that it is time for the CDC and WHO to make an unbiased review of their recommendations.

The Strengthening of Ebiox

Over the past few months Ebiox has been working to enhance and extend their product offering, as well as strengthening their financial position as part of ongoing plans for growth.

New Trionic D Wipe Dispensing System

Ebiox has launched its new dispensing system utilising the well proven and accepted Trionic D Wipes for cleaning and disinfection. Ideally suited for smaller clinical areas and ambulances with a wall mounted perspex holder and a flat pack of 50 medium size wipes which can be replaced when empty.

Natural Esense

Natural Esense is their first hand hygiene product based on sustainable natural ingredients, Natural Esense™. Extracted from the pith of Seville Oranges (Citrus Aurantium), Natural Esense is a proprietary formula, and is classed under the Bioflavonoid Complex classification.

Tested extensively to European regulatory standards and other supporting studies, Natural Esense provides effective bacterial, virucidal, fungicidal and sporicidal protection.

There is a growing interest in non alcohol based products especially within hand hygiene with Infection Prevention and Control teams looking for answers to help drive forward the levels of compliance to their hand hygiene protocols.

Natural Esense will be made available in a variety of dispensing systems.

Trionic A2Z Dry Mist System

Following extensive redesign and upgrade programme led by Amazon Bio-Guard Ltd, Ebiox has launched the new system for total room or vehicle disinfection.

There is a growing demand for total room or vehicle disinfection and there are a number of competitors already offering such devices into our market sector, however there can be a number of issues with the current offering, process time, complex protocols, complex systems, cost, damage to materials in the room and surface wetting.

The Trionic A2Z Area Disinfection System has a number of features which provides answers to a number of these issues:
Simple and easy to use system
No complex protocols
Shorter process times
No surface wetting
Very Cost effective
Use as an ongoing preventative measure

We believe this is an excellent addition to our product portfolio, one which offers many opportunities and the potential for pull through of other products such as Trionic wipes. Our aim as Ebiox is to offer a comprehensive range of solutions for Infection Prevention and Control.

Financial

The Directors of Ebiox Limited are pleased to announce that the company has completed a rights issue of £700,000 to strengthen its balance sheet and provide further working capital funding to grow the business.

The Directors were informed in July 2011 that Healthcare Enterprise Group plc had been put into liquidation, but would note that Healthcare Enterprise Group plc ceased to own Ebiox Limited in July 2009 and current shareholding only represents 7% of the Company’s ordinary share capital.